Filing Flows › Comparisons › HRGN vs PLSE
Harvard Apparatus Regenerative Technology vs Pulse Biosciences: HRGN and PLSE compared
Harvard Apparatus Regenerative Technology is the larger company: $414K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026). Pulse Biosciences is growing faster (+359% against +31% a year earlier).
Where the money goes: HRGN and PLSE
Harvard Apparatus Regenerative Technology (HRGN) · Q2 2026
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart follows the revenue to costs, profit and cash.
Pulse Biosciences (PLSE) · Q3 2026
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
| Harvard Apparatus Regenerative Technology (HRGN) | Pulse Biosciences (PLSE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $414K | $395K |
| Revenue growth, Y/Y | +31% | +359% |
| Operating margin | -408.7% | n/m |
| Net earnings | −$1.7M | −$23.1M |
| Net margin | -409.4% | — |
| Operating cash flow | −$569K | −$15.3M |
Questions
Which is bigger, Harvard Apparatus Regenerative Technology or Pulse Biosciences?
Harvard Apparatus Regenerative Technology is the larger company: $414K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026).
Is Harvard Apparatus Regenerative Technology or Pulse Biosciences growing faster?
Pulse Biosciences is growing faster (+359% against +31% a year earlier).
More: Harvard Apparatus Regenerative Technology earnings · how Harvard Apparatus Regenerative Technology makes money · Pulse Biosciences earnings · how Pulse Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.